|Date & Time||22 March 2022 at 09:00-11:00 CET|
MedTech products’ pricing and reimbursement (P&R) processes, if any, vary widely across Europe and for example in the United States. In addition, market access routes for MedTech products differ and this also applies to private and public sector practices by country.
The awareness of these issues is important as companies may face many challenges in this field. Therefore, you are welcome to join this webinar dedicated to both Medical Device, In Vitro Diagnostic and eHealth related products.
MedTech Pricing and Reimbursement System webinar
Knowledge of price and reimbursement issues are an essential part of a company’s sales and marketing activities. As pricing and reimbursement systems differ significantly between countries, the webinar presents Finland, Germany, the United Kingdom, France, and the United States as examples.
This webinar is intended for start-ups and R&D companies who need information on various market entry routes and channels that may involve Health technology assessment (HTA) and reimbursement of healthcare systems. The webinar is also for companies that want to expand their understanding of systems in different countries.
Agenda (Finnish time)
10:00 -10:05 Introduction, Turku Science Park Ltd
10:05 -10:25 Practice in Finland and background in Market Access, Lauri Seppälä, Sailab
10:25 -10:45 Practice in Germany – The DiGA pathway and other reimbursement options, Olivier Flückiger, RoX Health
10:45 -11:15 Practice in UK, France, and USA, Miika Talvitie, PerkinElmer
11:15~12:00 Questions and Discussion
More information about the speakers:
Lauri Seppälä works as an Industrial Policy Specialist at Sailab – MedTech Finland, an association for companies operating in the Finnish medical device and in vitro diagnostics market. Sailab – MedTech Finland’s members cover about 80–90 % of all medical technology manufactured and distributed in Finland. Lauri is responsible for public procurement, market access and other industrial policies. Lauri’s educational background is Master of Science in Economics.
Dr Olivier Flückiger is co-founder of RoX Health, a company builder and accelerator in the field of digital health solutions based in Berlin. Olivier is a medical doctor with additional studies in political management & public affairs. After his time in hospital, he gained over 16 years of experience in various research-based pharmaceutical companies in the fields of medicine and market access. At RoX Health, he is responsible for the Accelerator and the areas of Medicine and Market Access.
Miika Talvitie works as Commercial Excellence & Channel Operations Leader at PerkinElmer. During his nearly two-decade career he has been working in various functions including Manufacturing, R&D, Application support, Sales and Commercial Operations. He holds degrees from University of Jyväskylä (M.Sc. Molecular Biology), and Turku School of Economics (Executive MBA).
The webinar is partly funded by the Regional Council of Southwest Finland’s AKKE project that is supporting the sustainability and vitality of regions.